Treatment of restless legs syndrome with gabapentin: A double-blind, cross-over study

Neurology

Volumn 59, Issue 10, 2002, Pages 1573-1579

  Garcia Borreguero, Diego ^a,d   Larrosa, O ^a   De la Llave, Y ^a   Verger, K ^b   Masramon, X ^b   Hernandez, G ^c  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Euroclin   (Spain)

^c PFIZER INC   (United States)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; CARBAMAZEPINE; CLONIDINE; DEXTROPROPOXYPHENE; GABAPENTIN; LEVODOPA; OPIATE; OXYCODONE; PERGOLIDE; PRAMIPEXOLE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRY EYE; DYSPEPSIA; DYSPNEA; HEADACHE; HUMAN; IRON DEFICIENCY; MALAISE; NAUSEA; PAIN ASSESSMENT; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESS LEGS SYNDROME; SOMNOLENCE; XEROSTOMIA;

EID: 0037180403     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.10.1573     Document Type: Article

References (48)

1. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: The MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000;54:1064-1068.
2. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-2141.
3. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-642.
4. Picchietti DL, Underwood DJ, Farris WA, et al. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord 1999;14:1000-1007.
5. Picchietti DL, England SJ, Walters AS, Willis K, Verrico T. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 1998;13:588-594.
6. Gibb WR, Lees AJ. The restless legs syndrome. Postgrad Med J 1986;62:329-333.
7. Walters AS, Hening WA, Chokroverty S. Review and video-tape recognition of idiopathic restless legs syndrome. Mov Disord 1991;6:105-110.
8. Allen RP, Earley CJ. Restless legs syndrome: A review of clinical and pathophysiologic features. J Clin Neurophysiol 2001;18:128-147.
9. Pelletier G, Lorrain D, Montplaisir J. Sensory and motor components of the restless legs syndrome. Neurology 1992;42:1663-1666.
10. Pollmacher T, Schulz H. Periodic leg movements (PLM): Their relationship to sleep stages. Sleep 1993;16:572-577.
11. Trenkwalder CAW, Walters AS, Hening W. Periodic limb movements and restless legs syndrome. Neurol Clin 1996;14:629-650.
12. Chaudhuri KR, Appiah-Kubi LS, Trenkwalder C. Restless legs syndrome. J Neurol Neurosurg Psychiatry 2001;71:143-146.
13. Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol 1982;39:739.
14. Brodeur C, Montplaisir J, Godbout R, Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: A double-blind, controlled study. Neurology 1988;38:1845-1848.
15. Collado-Seidel V, Kazenwadel J, Wetter TC, et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology 1999;52:285-290.
16. Benes H, Kurella B, Kummer J, Kazenwadel J, Selzer R, Kohnen R. Rapid onset of action of levodopa in restless legs syndrome: A double-blind, randomized, multicenter, crossover trial. Sleep 1999;22:1073-1081.
17. Walters AS, Hening WA, Kavey N, Chokroverty S, Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 1988;24:455-458.
18. Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999;52:944-950.
19. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: A double-blind randomized trial. Neurology 1999;52:938-943.
20. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996;19:205-213.
21. Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993;16:327-332.
22. Kaplan PW, Allen RP, Buchholz DW, Walters JK. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 1993;16:717-723.
23. Boghen D, Lamothe L, Elie R, Godbout R, Montplaisir J. The treatment of the restless legs syndrome with clonazepam: A prospective controlled study. Can J Neurol Sci 1986;13:245-247.
24. Montagna P, Sassoli de Bianchi L, Zucconi M, Cirignotta F, Lugaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984;69:428-430.
25. Wagner ML, Walters AS, Coleman RG, Hening WA, Grasing K, Chokroverty S. Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep 1996;19:52-58.
26. Telstad W, Sorensen O, Larsen S, Lillevold PE, Stensrud P, Nyberg-Hansen R. Treatment of the restless legs syndrome with carbamazepine: A double blind study. BMJ (Clin Res Ed) 1984;288:444-446.
27. Backonja MM. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: A multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. Epilepsia 1999;40:S57-S59.
28. Gorson KC, Schott C, Herman R, Ropper AH, Rand WM. Gabapentin in the treatment of painful diabetic neuropathy: A placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 1999;66:251-252.
29. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998;280:1831-1836.
30. Adler CH. Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol 1997;20:148-151.
31. Mellick GA, Mellick LB. Management of restless legs syndrome with gabapentin (Neurontin). Sleep 1996;19:224-226.
32. Ehrenberg B. Importance of sleep restoration in co-morbid disease: Effect of anticonvulsants. Neurology 2000;54(suppl 1):S33-37.
33. Happe S, Klösch G, Saletu B, Zeitlhofer J. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 2001;57:1717-1719.
34. Thorp ML, Morris CD, Bagby SP. A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis 2001;38:104-108.
35. Montplaisir J, Boucher S, Nicolas A, et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord 1998;13:324-329.
36. Walters AS, Hening W, Rosen R, LeClerq C, Hirsch LC, Dhar A. A test of the reliability and validity of a brief, patient-completed severity questionnaire for the restless legs syndrome: The International RLS Study Group Rating Scale. Sleep 2001;24:A356. Abstract.
37. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
38. Guy W. ECDEU Assessment Manual for Psychopharmacology. Publication (ADM) 76-338. Washington, DC: Department of Health, Education and Welfare, 1976;217.
39. Rechtschaffen A, Kales A, eds. A Manual of Standardized Ter Minology. Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA, 1968.
40. Coleman RM, Pollak CP, Weitzman ED. Periodic movements in sleep (nocturnal myoclonus): Relation to sleep disorders. Ann Neurol 1980;8:416-421.
41. Earley CJ, Allen RP. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1996;19:801-810.
42. Koller WC, Silver DE, Lieberman A. An algorithm for the management of Parkinson's disease. Neurology 1994;44:S1-S52.
43. Allen RP, Earley CJ. Restless legs syndrome: A review of clinical and pathophysiologic features. J Clin Neurophysiol 2001;18:128-147.
44. 3H)gabapentin binding to a novel site in rat brain: Homogenate binding studies. Eur J Pharmacol 1993;244:293-301.
45. Taylor CP. An update on the possible mechanisms of action of gabapentin. Dolor 1999;14:237-242.
46. Fink K, Meder W, Dooley DJ, Gothert M. Inhibition of neuronal Ca-2+ influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol 2000;130:900-906.
47. Pugsley TA, Whetzel SZ, Dooley DJ. Reduction of 3,4-diaminopyridine-induced biogenic amine synthesis and release in rat brain by gabapentin. Psychopharmacology 1998;137:74-80.
48. Ondo W, Jankovic J. Restless legs syndrome. Clinicoetiologic correlates. Neurology 1996;47:1435-1441.